Dofferhoff A S, Esselink M T, de Vries-Hospers H G, van Zanten A, Bom V J, Weits J, Vellenga E
Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
J Antimicrob Chemother. 1993 Mar;31(3):373-84. doi: 10.1093/jac/31.3.373.
The influence of antibiotic-induced release of endotoxin from in-vitro grown Escherichia coli on the production of tumour necrosis factor-alpha (TNF) by human monocytes was studied. Antibiotics tested were: cefuroxime (7.5 and 75 mg/L); ceftazidime (10 and 100 mg/L); aztreonam (10 and 100 mg/L); imipenem (10 and 100 mg/L); and tobramycin (8 mg/L). The effect of the combination of cefuroxime plus tobramycin, and the effect of taurolidine, an endotoxin-binding agent, on TNF production was also tested. After incubation for 4 h, all antibiotic-treated cultures (high-dose) induced a similar rise in extracellular TNF production when compared to the controls. However, after incubation for 24 h, a significant rise in TNF production was noticed in the cefuroxime and aztreonam-treated cultures (6440 and 5969 ng/L, respectively) compared to the ceftazidime and imipenem-treated cultures (846 and 381 ng/L, respectively). The cefuroxime-induced release of TNF could be reduced by addition of tobramycin (from 6440 to 1615 ng/L). Similar differences in TNF production were noticed in cell-associated TNF. Dose-response curves did not demonstrate differences in TNF production in aztreonam or imipenem-treated cultures. However, for both cefuroxime and ceftazidime-treated cultures, low-dose treatment resulted in significantly higher production of TNF. The differences in TNF production between these antibiotics could be explained by the production of filaments following treatment with cefuroxime, aztreonam and low-dose ceftazidime, resulting in late bacterial lysis with high levels of endotoxin, whereas treatment with imipenem or high-dose ceftazidime resulted in the formation of spheroplasts, resulting in early lysis of the bacteria and much lower levels of endotoxin. The addition of taurolidine to either imipenem or aztreonam-treated cultures prevented a rise in TNF production as a result of nearly complete neutralization of the released endotoxin. It was concluded that the observed differences in TNF production by human monocytes in vitro were related to differences in the mechanisms and amount of antibiotic-induced release of endotoxin.
研究了抗生素诱导体外培养的大肠杆菌释放内毒素对人单核细胞产生肿瘤坏死因子-α(TNF)的影响。所测试的抗生素有:头孢呋辛(7.5和75mg/L);头孢他啶(10和100mg/L);氨曲南(10和100mg/L);亚胺培南(10和100mg/L);以及妥布霉素(8mg/L)。还测试了头孢呋辛加妥布霉素的组合以及内毒素结合剂牛磺罗定对TNF产生的影响。孵育4小时后,与对照相比,所有经抗生素处理的培养物(高剂量)诱导细胞外TNF产生出现类似的升高。然而,孵育24小时后,与头孢他啶和亚胺培南处理的培养物(分别为846和381ng/L)相比,头孢呋辛和氨曲南处理的培养物中TNF产生显著升高(分别为6440和5969ng/L)。添加妥布霉素可降低头孢呋辛诱导的TNF释放(从6440降至1615ng/L)。在细胞相关的TNF中也观察到类似的TNF产生差异。剂量反应曲线未显示氨曲南或亚胺培南处理的培养物中TNF产生的差异。然而,对于头孢呋辛和头孢他啶处理的培养物,低剂量处理导致TNF产生显著更高。这些抗生素之间TNF产生的差异可以解释为,头孢呋辛、氨曲南和低剂量头孢他啶处理后产生丝状菌,导致后期细菌裂解并释放高水平内毒素,而亚胺培南或高剂量头孢他啶处理导致形成原生质球,导致细菌早期裂解且内毒素水平低得多。在亚胺培南或氨曲南处理的培养物中添加牛磺罗定可防止TNF产生增加,因为释放的内毒素几乎被完全中和。得出的结论是,体外观察到的人单核细胞TNF产生差异与抗生素诱导内毒素释放的机制和量的差异有关。